Clinical efficacy of intradermal type I collagen injections in treating skin photoaging in patients from high-altitude areas

doi:10.12998/wjcc.v12.i16.2713

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1870)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

HTML

1132

Figures (1-3)

158

Tables (1-6)

160

Sum=1490

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

257

Sum=318

Jun 6, 2024 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Jun 6, 2024; 12(16): 2713-2721
Published online Jun 6, 2024. doi: 10.12998/wjcc.v12.i16.2713

Table 1 Inclusion and exclusion criteria

Inclusion criteria	Exclusion criteria
Age ≥ 18 yr, male or female	Pregnancy or lactation
Glogau photoaging score of II or III	Systemic diseases, such as diabetes, autoimmune diseases, and severe heart, liver, and kidney dysfunction
Residing in areas with an altitude of ≥ 1800 m for > 10 yr	Current treatment with glucocorticoids, estrogen, and other drugs that may cause facial pigmentation and affect the experimental results
Voluntarily receiving intradermal injection of Sunmax Col for facial rejuvenation and signing informed consent forms	Facial laser, freezing, and other treatments within the past 3 months
	Facial filling or botulinum toxin injection within the past 6 months
	Known allergies to Col or other ingredients in Sunmax Col
	Failure to follow up as planned or data loss affecting the evaluation of efficacy

Table 2 Face-Q scale content

Scale name	Content
Face-Q-Satisfaction with Facial Appearance Overall	Evaluates overall facial appearance
Face-Q-Satisfaction with Skin	Evaluates facial skin texture, color, and overall appearance
Face-Q-Satisfaction with Outcome	Evaluates the results of facial cosmetic treatments
Face-Q-Satisfaction with Decision	Evaluates decision-making regarding facial cosmetic treatments
Face-Q-Social Function	Evaluates the impact of facial appearance on social interactions
Face-Q-Psychological Function	Evaluates the psychological impact of facial appearance
Face-Q-Adverse Effects: Skin	Evaluates adverse reactions of the facial skin after treatment

Table 3 Comparison of skin thickness before and after intradermal injection of Col I (mm, mean ± SD)

	Baseline	1^st	2^nd	3^rd	4^th	5^th	6^th
Right cheek	1.65 ± 0.19	1.76 ± 0.22^a	1.88 ± 0.19^a	1.98 ± 0.16^a	2.04 ± 0.15^a	2.11 ± 0.17^a	2.15 ± 0.20^a
Left cheek	1.62 ± 0.21	1.69 ± 0.21	1.78 ± 0.19	1.90 ± 0.17^a	1.99 ± 0.12^a	2.06 ± 0.13^a	2.12 ± 0.16^a
Right zygomatic	1.57 ± 0.18	1.67 ± 0.20	1.79 ± 0.18^a	1.89 ± 0.16^a	1.96 ± 0.15^a	2.02 ± 0.14^a	2.08 ± 0.17^a
Left zygomatic	1.56 ± 0.22	1.63 ± 0.24	1.75 ± 0.23	1.86 ± 0.20	1.94 ± 0.18^a	2.01 ± 0.16^a	2.05 ± 0.15^a
Right temple	1.48 ± 0.25	1.54 ± 0.26	1.63 ± 0.24	1.75 ± 0.21	1.86 ± 0.18	1.96 ± 0.17^a	2.00 ± 0.20^a
Left temple	1.44 ± 0.24	1.52 ± 0.25	1.62 ± 0.26	1.73 ± 0.23	1.83 ± 0.20	1.94 ± 0.18^a	1.99 ± 0.16^a

^aP < 0.05, a statistically significant difference compared with before treatment.

Table 4 Comparison of VISIA parameters before and after intradermal injection of type I collagen (feature count, mean ± SD)

	Baseline	1^st	2^nd	3^rd	4^th	5^th	6^th
Red area	374.55 ± 22.89	325.25 ± 22.92^a	283.60 ± 23.08^a	244.35 ± 25.81^a	212.70 ± 28.48^a	189.85 ± 28.52^a	174.90 ± 27.18^a
Wrinkles	118.40 ± 16.43	114.80 ± 16.26	111.60 ± 16.64	108.80 ± 16.39	106.45 ± 16.21	104.30 ± 15.48	102.20 ± 15.29^a

^aP < 0.05, a statistically significant difference compared with before treatment.

Table 5 Comparison of Face-Q-Satisfaction with Facial Appearance Overall and Face-Q-Satisfaction with Skin scores before and after intradermal injection of type I collagen (mean ± SD)

	Baseline	1^st	2^nd	3^rd	4^th	5^th	6^th
Face-Q-Satisfaction with Facial Appearance Overall	40.05 ± 15.03	49.50 ± 14.86^a	57.50 ± 14.14^a	64.50 ± 12.47^a	72.50 ± 10.47^a	76.50 ± 9.56^a	80.40 ± 8.16^a
Face-Q-Satisfaction with Skin	34.05 ± 11.98	45.5 ± 12.33^a	55.25 ± 11.91^a	63.5 ± 9.73^a	73.6 ± 8.69^a	78.35 ± 8.11^a	82.40 ± 6.72^a

^aP < 0.01, a statistically significant difference compared with before treatment.

Table 6 Face-Q-Satisfaction with Outcome, Face-Q-Satisfaction with Decision, Face-Q-Social Function, Face-Q-Psychological Function, and Face-Q-Adverse Effects: Skin scores after 6 intradermal injections of type I collagen (mean ± SD)

Scale	Score
Face-Q-Satisfaction with Outcome	67.05 ± 15.50
Face-Q-Satisfaction with Decision	83.8 ± 14.50
Face-Q-Social Function	76.5 ± 8.7
Face-Q-Psychological Function	78.75 ± 7.5
Face-Q-Adverse Effects: Skin	13.85 ± 3.82

Citation: Yang B, He A, Bu BB, Zhuo G, Zhou QZ, He JH, Liu L, Huang WL, Zhao X. Clinical efficacy of intradermal type I collagen injections in treating skin photoaging in patients from high-altitude areas. World J Clin Cases 2024; 12(16): 2713-2721
URL: https://www.wjgnet.com/2307-8960/full/v12/i16/2713.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i16.2713